Surge Biswas, Nabla Bio CEO

Ex­clu­sive: Har­vard start­up rais­es $26M, strikes three phar­ma part­ner­ships for AI an­ti­body de­sign

Nabla Bio, a small start­up found­ed by sci­en­tists from ge­neti­cist George Church’s lab at Har­vard Med­ical School, has formed drug dis­cov­ery col­lab­o­ra­tions with As­traZeneca, Bris­tol …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.